Abstract
Background
Analysis of efficacy and tolerability of vortioxetine 20 mg/day, and optimal timing of dose adjustment, in patients with major depressive disorder (MDD).
Christensen, M., McIntyre, R., Florea, I., Loft, H., & Fagiolini, A. (2021). Vortioxetine 20 mg/day in patients with major depressive disorder: Updated analysis of efficacy, safety, and optimal timing of dose adjustment. CNS Spectrums, 1-8. doi:10.1017/S1092852921000936